Cargando…

Endovascular Treatment and Outcomes for Femoropopliteal In-Stent Restenosis: Insights from the XLPAD Registry

BACKGROUND: There is limited “real-world” evidence examining treatment modalities and outcomes in patients with symptomatic peripheral arterial disease undergoing endovascular treatment of femoropopliteal (FP) in-stent restenosis (ISR). MATERIALS AND METHODS: We compared outcomes in 2,895 patients f...

Descripción completa

Detalles Bibliográficos
Autores principales:	Vu, Michael H., Sande-Docor, Glaiza-Mae, Liu, Yulun, Tsai, Shirling, Patel, Mitul, Metzger, Chris, Shishehbor, Mehdi H., Brilakis, Emmanouil S., Shammas, Nicolas W., Monteleone, Peter, Banerjee, Subhash
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9307356/ https://www.ncbi.nlm.nih.gov/pubmed/35911663 http://dx.doi.org/10.1155/2022/5935039

Ejemplares similares

Comparative Outcomes of Interventions for Femoropopliteal Chronic Total Occlusion Versus Non–Chronic Total Occlusion Lesions From the Multicenter XLPAD Registry
por: Tsai, Shirling, et al.
Publicado: (2023)

Viabahn for femoropopliteal in-stent restenosis
por: Al Shammeri, Owayed, et al.
Publicado: (2012)

Treatment of Femoropopliteal Artery In-stent Restenosis
por: Kim, Wonho, et al.
Publicado: (2018)

Drug-Coated Balloon for the Treatment of Femoropopliteal Tosaka Class III In-stent Restenosis Lesions
por: Zhang, Bihui, et al.
Publicado: (2021)

Algorithm of Femoropopliteal Endovascular Treatment
por: Dubosq, Maxime, et al.
Publicado: (2022)

Long-term clinical effectiveness of a drug-coated balloon for in-stent restenosis in Femoropopliteal lesions
por: Horie, Kazunori, et al.
Publicado: (2021)

A better effect of cilostazol for reducing in-stent restenosis after femoropopliteal artery stent placement in comparison with ticlopidine
por: Ikushima, Ichiro, et al.
Publicado: (2011)

Design of the FP-RESTORE study: a protocol for prospective, observational study of real-world treatments with endovascular therapy in patients with femoropopliteal artery Tosaka III in-stent restenosis
por: Li, Xu, et al.
Publicado: (2022)

Drug-Coated Balloon Angioplasty and Debulking for the Treatment of Femoropopliteal In-Stent Restenosis: A Systematic Review and Meta-Analysis
por: Tong, Zhu, et al.
Publicado: (2020)

Atrial Fibrillation is Associated with Femoropopliteal Totally Occlusive In-Stent Restenosis: A Single-Center, Retrospective, Observational Study
por: Honda, Yohsuke, et al.
Publicado: (2021)

Drug-Eluting versus Bare-Metal Stent for Treatment of Saphenous Vein Grafts: A Meta-Analysis
por: Meier, Pascal, et al.
Publicado: (2010)

Peak systolic velocity ratio derived from quantitative vessel analysis for restenosis after femoropopliteal intervention: a multidisciplinary review from Endovascular Asia
por: Kawarada, Osami, et al.
Publicado: (2019)

Impact of Postoperative Lumen Gain on the Reduction of Restenosis Risk after Endovascular Treatment using Drug-coated Balloon for Femoropopliteal Lesions Assessed by Intravascular Ultrasound
por: Horie, Kazunori, et al.
Publicado: (2023)

Endovascular Sharp Recanalization for Calcified Femoropopliteal Artery Occlusion
por: Huang, Hsuan-Li, et al.
Publicado: (2012)

Lumivascular Optical Coherence Tomography–Guided Atherectomy in Recurrent Femoropopliteal Occlusive Diseases Associated with In-Stent Restenosis: Case-Series Report
por: Chan, Yiu Che, et al.
Publicado: (2020)

Drug-coated balloon angioplasty versus balloon angioplasty for treating patients with in-stent restenosis in the femoropopliteal artery: A meta-analysis
por: Cao, Shaobo, et al.
Publicado: (2021)

Effective Endovascular Treatment of Calcified Femoropopliteal Disease With Directional Atherectomy and Distal Embolic Protection: Final Results of the DEFINITIVE Ca(++) Trial
por: Roberts, David, et al.
Publicado: (2014)

State-of-the-Art Endovascular Therapies for the Femoropopliteal Segment: Are We There Yet?
por: Mosarla, Ramya C., et al.
Publicado: (2022)

Popliteal access for endovascular procedures in femoropopliteal artery occlusive disease
por: Yilmaz, Seyhan, et al.
Publicado: (2023)

Supera self-expanding stents for endovascular treatment of femoropopliteal disease: a review of the clinical evidence
por: Bishu, Kalkidan, et al.
Publicado: (2015)

Clinical Impact of Additional Cilostazol Treatment on Restenosis Risk following Heparin-Bonded Stent Graft Implantation: Sub-Analysis from the Viabahn Stent-Graft Placement for Femoropopliteal Diseases Requiring Endovascular Therapy (VANQUISH) Study
por: Tobita, Kazuki, et al.
Publicado: (2023)

Increased Plasma Cathepsin s at the Time of Percutaneous Transluminal Angioplasty is Associated with 6-months’ Restenosis of the Femoropopliteal Artery
por: Mijovski, Mojca Bozic, et al.
Publicado: (2018)

Possible effect of direct oral anti-coagulant for preventing long stenting lesion from in-stent restenosis in femoropopliteal segment: Case report with angioscopy findings
por: Tsuchiya, Taketsugu, et al.
Publicado: (2020)

Coronavirus Disease 2019 Catheterization Laboratory Survey
por: Banerjee, Subhash, et al.
Publicado: (2020)

Long-Term Results of Endovascular Treatment with Nitinol Stents for Femoropopliteal TASC II C and D Lesions
por: Kluckner, Michaela, et al.
Publicado: (2022)

Debulking plus drug-coated balloon angioplasty versus drug-coated balloon angioplasty alone for femoropopliteal Tosaka III in-stent restenosis lesions
por: Li, Liqiang, et al.
Publicado: (2022)

When Are Endovascular and Open Bypass Treatments Preferred for Femoropopliteal Occlusive Disease?
por: AbuRahma, Ali F.
Publicado: (2018)

Outcomes of endovascular treatment of patients with intermittent claudication due to femoropopliteal disease
por: Naiem, Ahmed A, et al.
Publicado: (2021)

Three-Year Patency Results following Endovascular Transvenous Femoropopliteal Bypass
por: Rumba, Roberts, et al.
Publicado: (2023)

Roles of MicroRNAs in Peripheral Artery In-Stent Restenosis after Endovascular Treatment
por: Wang, Mo, et al.
Publicado: (2021)

Economic analysis of endovascular drug-eluting treatments for femoropopliteal artery disease in the UK
por: Katsanos, Konstantinos, et al.
Publicado: (2016)

Impact of calcification and infrapopliteal outflow on the outcome of endovascular treatment of femoropopliteal occlusive disease
por: de Athayde Soares, Rafael, et al.
Publicado: (2019)

Morphologic Changes of the Femoropopliteal Arterial Segment with Knee Flexion after Endovascular Therapy
por: Sato, Katsutoshi, et al.
Publicado: (2019)

Association of Age with Mortality Rate after Femoropopliteal Endovascular Therapy for Intermittent Claudication
por: Takahara, Mitsuyoshi, et al.
Publicado: (2022)

Endovascular revascularization strategies for aortoiliac and femoropopliteal artery disease: a meta-analysis
por: Koeckerling, David, et al.
Publicado: (2023)

Restenosis of Aorto-renal Venous Grafts: Report of Two Patients Treated by Endovascular Stenting
por: Lemos Gomes, Miguel, et al.
Publicado: (2018)

Emerging Stent and Balloon Technologies in the Femoropopliteal Arteries
por: Pastromas, Georgios, et al.
Publicado: (2014)

A case of occluded femoropopliteal saphenous vein bypass with threatening limb ischemia treated with endovascular stent graft relining
por: Toyoshima, Taku, et al.
Publicado: (2020)

Importance to Know the Long-Term Outcome after Endovascular Therapy with Bare Metal Stent Implantation for Femoropopliteal Artery Disease
por: Ito, Naruhiko
Publicado: (2022)

Endovascular stent-induced alterations in host artery mechanical environments and their roles in stent restenosis and late thrombosis
por: Wang, Jinxuan, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_4bdse2a6c908nscgql5c6hllf4